Defective Protein Prenylation in a Spectrum of Patients With Mevalonate Kinase Deficiency.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 27 02 2019
accepted: 26 07 2019
entrez: 3 9 2019
pubmed: 3 9 2019
medline: 6 10 2020
Statut: epublish

Résumé

The rare autoinflammatory disease mevalonate kinase deficiency (MKD, which includes HIDS and mevalonic aciduria) is caused by recessive, pathogenic variants in the

Identifiants

pubmed: 31474985
doi: 10.3389/fimmu.2019.01900
pmc: PMC6702261
doi:

Substances chimiques

Biomarkers 0
Phosphotransferases (Alcohol Group Acceptor) EC 2.7.1.-
mevalonate kinase EC 2.7.1.36
rap1 GTP-Binding Proteins EC 3.6.5.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1900

Références

Nat Genet. 1999 Jun;22(2):175-7
pubmed: 10369261
Nat Genet. 1999 Jun;22(2):178-81
pubmed: 10369262
Eur J Hum Genet. 2001 Apr;9(4):260-6
pubmed: 11313769
Arthritis Rheum. 2002 Oct;46(10):2794-803
pubmed: 12384940
Hum Mol Genet. 2002 Dec 1;11(25):3115-24
pubmed: 12444096
Neurology. 2004 Mar 23;62(6):994-7
pubmed: 15037710
Eur J Hum Genet. 2005 Mar;13(3):314-20
pubmed: 15536479
Cell Mol Life Sci. 2006 Feb;63(3):255-67
pubmed: 16378247
Hum Mutat. 2006 Aug;27(8):796-802
pubmed: 16835861
Arthritis Rheum. 2006 Nov;54(11):3690-5
pubmed: 17075828
Rheumatology (Oxford). 2007 Oct;46(10):1597-600
pubmed: 17804452
Eur Cytokine Netw. 2009 Sep;20(3):112-20
pubmed: 19825520
Pediatrics. 2011 Jul;128(1):e152-9
pubmed: 21708801
Small GTPases. 2015 Oct 2;6(4):202-11
pubmed: 26399387
Ann Hum Genet. 2015 Nov;79(6):451-9
pubmed: 26420133
RMD Open. 2016 Mar 07;2(1):e000196
pubmed: 26977311
Arthritis Rheumatol. 2016 Nov;68(11):2795-2805
pubmed: 27213830
Immunol Cell Biol. 2016 Nov;94(10):994-999
pubmed: 27377765
J Allergy Clin Immunol. 2017 Sep;140(3):873-875.e6
pubmed: 28501347
Pediatrics. 1993 May;91(5):915-21
pubmed: 8386351

Auteurs

Marcia A Munoz (MA)

Bone Biology, Garvan Institute of Medical Research, Sydney & St Vincent's Clinical School, UNSW Sydney, Sydney, NSW, Australia.

Julie Jurczyluk (J)

Bone Biology, Garvan Institute of Medical Research, Sydney & St Vincent's Clinical School, UNSW Sydney, Sydney, NSW, Australia.

Anna Simon (A)

Department of Internal Medicine, Radboudumc Expertise Centre for Immunodeficiency and Autoinflammation, Radboud University Medical Centre, Nijmegen, Netherlands.

Pravin Hissaria (P)

Royal Adelaide Hospital, Adelaide, SA, Australia.

Rob J W Arts (RJW)

Department of Internal Medicine, Radboudumc Expertise Centre for Immunodeficiency and Autoinflammation, Radboud University Medical Centre, Nijmegen, Netherlands.

David Coman (D)

Queensland Children's Hospital, Brisbane, QLD, Australia.
School of Medicine, University of Queensland, Brisbane, QLD, Australia.
School of Medicine, Griffith University, Brisbane, QLD, Australia.

Christina Boros (C)

Department of Rheumatology, Women's and Children's Hospital, University of Adelaide Discipline of Paediatrics, Adelaide, SA, Australia.

Sam Mehr (S)

Department of Allergy and Immunology, Royal Children's Hospital, Melbourne, VIC, Australia.

Michael J Rogers (MJ)

Bone Biology, Garvan Institute of Medical Research, Sydney & St Vincent's Clinical School, UNSW Sydney, Sydney, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH